The second-largest stablecoin — a cryptocurrency that is pegged to a fiat currency — USCD depegged from the dollar, hitting an all-time low of around 88 cents over the weekend. While the coin has rebounded, it's still hovering just below the peg and could face additional volatility amid the ongoing collapse of Silicon Valley Bank. USCD reportedly held a significant amount of reserves at the embattled bank.
NEW MIGRAINE TREATMENT
The FDA has approved a new nasal spray for adults who suffer migraines. Pfizer said the spray, called Zavzpret, is considered a rapid rescue treatment and could relieve migraine pain within 15 minutes. The spray is also an alternative for people who have heart disease and other conditions that are preventing them from safely using other migraine treatments.
SLASHER SUCCESS
Scream VI topped the charts this weekend with $44.5 million dollars in ticket sales. It's the best debut in the franchise's history and a surprise box office success in the usually quiet month of March. The film follows the survivors of the last spate of Ghostface murders as they pursue a fresh start in New York City. Last year, the fifth Scream entry made about $30 million in ticket sales over a four-day holiday weekend
Co-founder and CEO of Colossal Ben Lamm explains how the company is working to bring back extinct species and shares early details of the upcoming documentary from the ‘My Octopus Teacher’ filmmaker.
Soundhound AI co-founder, president, and CEO Keyvan Mojaver discusses bringing its audio tools to cars and drive-thrus, plus why smaller companies may benefit from the A.I. boom.
Deiya Pernas, co-founder of Pernas Research, breaks down Nvidia’s blockbuster earnings, why energy is a sector to watch, and why the A.I. trend is far from over.
The NBA is organizing its next media rights deal to figure out which networks and streaming services will show their games for the next decade. Last time, most of the prominent streaming services didn't exist yet.
Jessica Traver Ingram, CEO and co-founder of IntuiTap Medical, discusses developing the company's Ver Touch device, the crucial FDA approval it just won, and why innovation in spinal blocks and epidurals is long overdue.
